The Crystal Structure of the Globular Domain of Sheep Prion Protein

Journal of Molecular Biology

Volumn 336, Issue 5, 2004, Pages 1175-1183

  Haire, L F ^a   Whyte, S M ^a   Vasisht, N ^a   Gill, A C ^b   Verma, C ^c,d   Dodson, E J ^c   Dodson, G G ^a,c   Bayley, P M ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d BIOINFORMATICS INSTITUTE   (Singapore)

Author keywords

Creutzfeld Jacob Disease; Protein structure; Scrapie; Transmissible spongiform encephalopathy; X ray crystallography

Indexed keywords

HELIX LOOP HELIX PROTEIN; PRION PROTEIN;

ALLELE; ARTICLE; ASYMMETRIC CATALYSIS; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; DISULFIDE BOND; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE;

BOVINAE; MAMMALIA; OVIS ARIES;

EID: 1242272068     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2003.12.059     Document Type: Article

References (49)

1. Prusiner S.B. Prions. Proc. Natl Acad. Sci. USA. 95:1998;13363-13383.
2. Jackson G.S., Collinge J. The molecular pathology of CJD: old and new variants. Mol. Pathol. 54:2001;393-399.
3. Caughey B. Prion protein interconversions. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:2001;200-202. discussion.
4. Chesebro B. Prion protein and the transmissible spongiform encephalopathy diseases. Neuron. 24:1999;503-506.
5. Wuthrich K., Riek R. Three-dimensional structures of prion proteins. Advan. Protein Chem. 57:2001;55-82.
6. Knaus K.J., Morillas M., Swietnicki W., Malone M., Surewicz W.K., Yee V.C. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nature Struct. Biol. 8:2001;770-774.
7. Glockshuber R. Folding dynamics and energetics of recombinant prion proteins. Advan. Protein Chem. 57:2001;83-105.
8. Fischer M., Rulicke T., Raeber A., Sailer A., Moser M., Oesch B., et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15:1996;1255-1264.
9. Flechsig E., Shmerling D., Hegyi I., Raeber A.J., Fischer M., Cozzio A., et al. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron. 27:2000;399-408.
10. Shmerling D., Hegyi I., Fischer M., Blattler T., Brandner S., Gotz J., et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell. 93:1998;203-214.
11. Caughey B.W., Dong A., Bhat K.S., Ernst D., Hayes S.F., Caughey W.S. Secondary structure analysis of the scrapie-associated protein PrP27-30 in water by infrared spectroscopy. Biochemistry. 30:1991;7672-7680.
12. Safar J., Roller P.P., Gajdusek D.C., Gibbs C.J. Jr. Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity. Protein Sci. 2:1993;2206-2216.
13. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl Acad. Sci. USA. 90:1993;10962-10966.
14. Baldwin M.A., Pan K.M., Nguyen J., Huang Z., Groth D., Serban A., et al. Spectroscopic characterization of conformational differences between PrPC and PrPSc: an alpha-helix to beta-sheet transition. Philos. Trans. R. Soc. Lond. B Biol. Sci. 343:1994;435-441.
15. Whyte S.M., Sylvester I.D., Martin S.R., Gill A.C., Wopfner F., Schatzl H.M., et al. Stability and conformational properties of doppel, a prion-like protein, and its single-disulphide mutant. Biochem. J. 373:2003;485-494.
16. Gill S.C., von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:1989;319-326.
17. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallog. sect. A. 50:1994;157-163.
18. Jones T.A., Zhou J.Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A. 47:1991;110-119.
19. CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D. 50:1994;760-763.
20. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallog. sect. D Biol. Crystallog. 54:1998;905-921.
21. Brooks B., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., Karplus M. CHARMM - a program for macromolecular energy minimization and dynamics. J. Comput. Chem. 4:1983;187-217.
22. Neria E., Fischer S., Karplus M. Simulation of activation free energies in molecular systems. J. Chem. Phys. 105:1996;1902-1921.
23. Swietnicki W., Petersen R., Gambetti P., Surewicz W.K. pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231). J. Biol. Chem. 272:1997;27517-27520.
24. Hornemann S., Glockshuber R. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH. Proc. Natl Acad. Sci. USA. 95:1998;6010-6014.
25. Swietnicki W., Morillas M., Chen S.G., Gambetti P., Surewicz W.K. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry. 39:2000;424-431.
26. Zou W.Q., Cashman N.R. Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form. J. Biol. Chem. 277:2002;43942-43947.
27. Caughey B., Raymond G.J., Ernst D., Race R.E. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J. Virol. 65:1991;6597-6603.
28. Borchelt D.R., Taraboulos A., Prusiner S.B. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem. 267:1992;16188-16199.
29. Welker E., Raymond L.D., Scheraga H.A., Caughey B. Intramolecular versus intermolecular disulfide bonds in prion proteins. J. Biol. Chem. 277:2002;33477-33481.
30. Calzolai L., Zahn R. Influence of pH on NMR structure and stability of the human prion protein globular domain. J. Biol. Chem. 278:2003;35592-35596.
31. Telling G.C., Scott M., Mastrianni J., Gabizon R., Torchia M., Cohen F.E., et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell. 83:1995;79-90.
32. Ryou C., Prusiner S.B., Legname G. Cooperative binding of dominant-negative prion protein to kringle domains. J. Mol. Biol. 329:2003;323-333.
33. Kaneko K., Zulianello L., Scott M., Cooper C.M., Wallace A.C., James T.L., et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl Acad. Sci. USA. 94:1997;10069-10074.
34. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R., Wuthrich K. NMR structure of the mouse prion protein domain PrP(121-231). Nature. 382:1996;180-182.
35. Will R.G., Ironside J.W., Zeidler M., Cousens S.N., Estibeiro K., Alperovitch A., et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 347:1996;921-925.
36. Wopfner F., Weidenhofer G., Schneider R., von Brunn A., Gilch S., Schwarz T.F., et al. Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J. Mol. Biol. 289:1999;1163-1178.
37. Brown P., Bradley R. 1755 and all that: a historical primer of transmissible spongiform encephalopathy. Bmj. 317:1998;1688-1692.
38. Dobson C.M. Protein folding and its links with human disease. Biochem. Soc. Symp. 2001;1-26.
39. Nguyen J.T., Inouye H., Baldwin M.A., Fletterick R.J., Cohen F.E., Prusiner S.B., Kirschner D.A. X-ray diffraction of scrapie prion rods and PrP peptides. J. Mol. Biol. 252:1995;412-422.
40. Peretz D., Williamson R.A., Matsunaga Y., Serban H., Pinilla C., Bastidas R.B., et al. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J. Mol. Biol. 273:1997;614-622.
41. Paramithiotis E., Pinard M., Lawton T., LaBoissiere S., Leathers V.L., Zou W.Q., et al. A prion protein epitope selective for the pathologically misfolded conformation. Nature Med. 9:2003;893-899.
42. Tagliavini F., Lievens P.M., Tranchant C., Warter J.M., Mohr M., Giaccone G., et al. A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Straussler-Scheinker disease A117V. J. Biol. Chem. 276:2001;6009-6015.
43. Wille H., Michelitsch M.D., Guenebaut V., Supattapone S., Serban A., Cohen F.E., et al. Structural studies of the scrapie prion protein by electron crystallography. Proc. Natl Acad. Sci. USA. 99:2002;3563-3568.
44. Jansen K., Schafer O., Birkmann E., Post K., Serban H., Prusiner S.B., Riesner D. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form. Biol. Chem. 382:2001;683-691.
45. Come J.H., Fraser P.E., Lansbury P.T. Jr. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl Acad. Sci. USA. 90:1993;5959-5963.
46. Eigen M. Prionics or the kinetic basis of prion diseases. Biophys. Chem. 63:1996;A1-18.
47. Serio T.R., Cashikar A.G., Kowal A.S., Sawicki G.J., Moslehi J.J., Serpell L., et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science. 289:2000;1317-1321.
48. Kelly J.W. Mechanisms of amyloidogenesis. Nature Struct. Biol. 7:2000;824-826.
49. Bosques C.J., Imperiali B. The interplay of glycosylation and disulfide formation influences fibrillization in a prion protein fragment. Proc. Natl Acad. Sci. USA. 100:2003;7593-7598.